Is there an effect of glucose lowering treatment on incidence and prognosis of tuberculosis? A systematic review (Q38210065)

31 August 2017

Is there an effect of glucose lowering treatment on incidence and prognosis of tuberculosis? A systematic review (English)

1 reference

31 August 2017

1 reference

Daniel Faurholt-Jepsen

object named as

Daniel Faurholt-Jepsen

series ordinal

2

0 references

Marit E. Jørgensen

object named as

Marit Eika Jørgensen

series ordinal

1

0 references

publication date

1 July 2014

1 reference

31 August 2017

Current diabetes report

1 reference

31 August 2017

14

1 reference

31 August 2017

7

1 reference

31 August 2017

505

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-014-0505-1

31 August 2017

0 references

cites work

Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Tuberculosis and diabetes mellitus: convergence of two epidemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

The role of diabetes on the clinical manifestations of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

The role of diabetes co-morbidity for tuberculosis treatment outcomes: a prospective cohort study from Mwanza, Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Diabetes is a strong predictor of mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients from Mwanza, Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Role of diabetes in the prognosis and therapeutic outcome of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Aggressive regimens for multidrug-resistant tuberculosis reduce recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Impact of diabetes on treatment outcomes and long-term survival in multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Incidence and outcome of newly-diagnosed tuberculosis in schizophrenics: a 12-year, nationwide, retrospective longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Diabetes mellitus and tuberculosis: pattern of tuberculosis, two-month smear conversion and treatment outcomes in Guangzhou, China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Outcome of tuberculosis treatment in patients with diabetes mellitus treated in the revised national tuberculosis control programme in Malappuram District, Kerala, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Predictors of tuberculosis treatment outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Impact of diabetes and smoking on mortality in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Socio-demographic and clinical differences in subjects with tuberculosis with and without diabetes mellitus in Brazil--a multivariate analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Risk factors for poor treatment outcomes in patients with MDR-TB and XDR-TB in China: retrospective multi-center investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Impact of type 2 diabetes on manifestations and treatment outcome of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Risk factors for recurrence of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Pharmacokinetics of antituberculosis drugs in pulmonary tuberculosis patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Therapeutic drug monitoring in the treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Rationale and design of a randomized controlled trial of the effect of retinol and vitamin D supplementation on treatment in active pulmonary tuberculosis patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

"For someone who's rich, it's not a problem". Insights from Tanzania on diabetes health-seeking and medical pluralism among Dar es Salaam's urban poor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Intensive insulin therapy in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Intensive insulin therapy in the medical ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Intensive insulin therapy in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

New screening technologies for type 2 diabetes mellitus appropriate for use in tuberculosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Megatrials in type 2 diabetes. From excitement to frustration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Hyperglycemia in the critically ill patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Type 2 diabetes and tuberculosis in a dynamic bi-national border population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

Clinical characteristics, drug resistance, and treatment outcomes among tuberculosis patients with diabetes in Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-014-0505-1

A high tuberculosis case-fatality rate in a setting of effective tuberculosis control: implications for acceptable treatment success rates

21 January 2018

1 reference

12 December 2020

Saxagliptin and tuberculosis

1 reference

12 December 2020

Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients.

1 reference

12 December 2020

Pharmacokinetics of rifampicin

1 reference

12 December 2020

Insulin requirements in the intensive care unit in response to infection

1 reference

12 December 2020

The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis

1 reference

12 December 2020

Tuberculosis in Hong Kong-patient characteristics and treatment outcome.

1 reference

12 December 2020

Morbidity and mortality at five years after initiating Category I treatment among patients with new sputum smear positive pulmonary tuberculosis

1 reference

12 December 2020

Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors

1 reference

12 December 2020

Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis

1 reference

12 December 2020

Tuberculosis in diabetics: features in an endemic area.

1 reference

12 December 2020

Factors that effect sputum culture conversion rate in hospitalized patients with pulmonary tuberculosis who were applied directly observation therapy and non-directly observation therapy.

1 reference

12 December 2020

Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis

1 reference

12 December 2020

Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors

1 reference

12 December 2020

Factors changing the manifestation of pulmonary tuberculosis.

1 reference

12 December 2020

Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance

1 reference

12 December 2020

Tuberculosis outcomes in Taipei: factors associated with treatment interruption for 2 months and death

1 reference

12 December 2020

10.1007/S11892-014-0505-1

Identifiers

DOI

1 reference

PubMed ID

24806518

Dimensions Publication ID

31 August 2017

0 references

1 reference

PubMed ID

24806518